Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause issued through third-party allotment
66th Series Stock Acquisition Rights: 880,000 new shares; 58th Series Stock Acquisition Rights: 0 new shares
The lower thin line represents the existing number of shares to which these shares will be added.
1.8% (exercise ratio relating to the exercise restriction; 880,000 shares delivered during the relevant month / 48,855,455 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause issued through third-party allotment |
| Number of shares to be issued or disposed of | 66th Series Stock Acquisition Rights: 880,000 new shares; 58th Series Stock Acquisition Rights: 0 new shares |
| Intended allottee | Series 66 Stock Acquisition Rights: EVO FUND; Series 58 Stock Acquisition Rights: CVI Investments, Inc. |
| Dilution Rate | 1.8% (exercise ratio relating to the exercise restriction; 880,000 shares delivered during the relevant month / 48,855,455 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 75,472,485 shares (as of the end of the month preceding the relevant month, including 91,169 treasury shares) → Not disclosed |
| Exercise price | 66th Series Stock Acquisition Rights: ¥84–¥92 during the relevant month; 58th Series Stock Acquisition Rights: ¥86 or ¥84. Subject to an exercise price adjustment clause. The lower limit of the adjustment is not disclosed. |
| Number of Stock Acquisition Rights | 66th Series Stock Acquisition Rights: total issued, 200,000; unexercised at the end of the preceding month, 167,800; unexercised at the end of the relevant month, 159,000. 58th Series Stock Acquisition Rights: total issued, 20,000; unexercised at the end of the preceding month, 20,000; unexercised at the end of the relevant month, 20,000. |
| Procedures under the Corporate Code of Conduct | Disclosure of compliance with the exercise restrictions under Article 434 of the Listing Regulations. The total number of shares delivered across all series was 880,000, and the exercise ratio relating to the exercise restriction was 1.8%. |
| Most recent equity financing | 1 June 2022: Issuance of the 58th Series Stock Acquisition Rights, 12 August 2025: Issuance of the 65th through 67th Series Stock Acquisition Rights |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 58th Series Stock Acquisition Rights are deemed to constitute MSCBs, etc., and therefore became subject to disclosure of monthly exercise status. Disclosure of monthly exercise status for the 67th Series Stock Acquisition Rights has been omitted because, in principle, they are structured so that they cannot be exercised until 13 August 2027.